Yusuke Nakano

Beppu, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

Journal: Cancer science
Published: October 26, 2025

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.

Journal: Cancer science
Published: May 29, 2025

Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.

Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology
Published: April 03, 2025

Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma.

Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma.

Journal: Cancer science
Published: March 16, 2025

SEC61G promotes colorectal cancer progression by regulating cytosolic Ca2+ concentration.

SEC61G promotes colorectal cancer progression by regulating cytosolic Ca2+ concentration.

Journal: Journal of gastroenterology
Published: February 06, 2025

Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma.

Identification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 10, 2025

Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression.

Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression.

Journal: Cancer science
Published: January 05, 2025

SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.

SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.

Journal: International journal of oncology
Published: February 13, 2024

Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.

Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.

Journal: EBioMedicine
Published: October 18, 2023

Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer.

Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer.

Journal: Cancer science
Published: July 26, 2023

Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence.

Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence.

Journal: International cancer conference journal
Published: November 24, 2022

Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma.

Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma.

Journal: British journal of cancer
Published: April 30, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026